Human Pathology
Volume 41, Issue 1 , Pages 123-128, January 2010

Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas☆

  • Brody Winn, MD

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • Rosemarie Tavares, BSc

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • Andres Matoso, MD

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • Lelia Noble

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • Jacqueline Fanion, MSc

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • Scott A. Waldman, MD, PhD

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Murray B. Resnick, MD, PhD

      Affiliations

    • Department of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
    • Corresponding Author InformationCorresponding author.

Received 6 April 2009; received in revised form 13 July 2009; accepted 16 July 2009. published online 05 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ S. A. Waldman is a paid consultant for Merck Research Laboratories and is the Chair (uncompensated) of the Scientific Advisory Board for Targeted Diagnostics and Therapeutics, Inc, West Chester, PA, which sponsors research and has a license to commercialize diagnostic and therapeutic products related to Guanylyl cyclase C.

PII: S0046-8177(09)00259-7

doi:10.1016/j.humpath.2009.07.009

Human Pathology
Volume 41, Issue 1 , Pages 123-128, January 2010

Article Tools

* Image Usage & Resolution